Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diagnosis | 4 | 2022 | 157 | 0.960 |
Why?
|
Hospital Administration | 3 | 2021 | 353 | 0.940 |
Why?
|
Employee Incentive Plans | 2 | 2013 | 15 | 0.900 |
Why?
|
Public Health Practice | 4 | 2022 | 219 | 0.900 |
Why?
|
Influenza A Virus, H1N1 Subtype | 4 | 2014 | 445 | 0.880 |
Why?
|
Delivery of Health Care | 15 | 2022 | 5336 | 0.880 |
Why?
|
Health Policy | 12 | 2022 | 2684 | 0.870 |
Why?
|
Government Regulation | 4 | 2022 | 524 | 0.860 |
Why?
|
Preventive Medicine | 3 | 2013 | 246 | 0.850 |
Why?
|
Science | 2 | 2020 | 239 | 0.800 |
Why?
|
Policy Making | 5 | 2017 | 542 | 0.770 |
Why?
|
Primary Prevention | 3 | 2013 | 1186 | 0.760 |
Why?
|
Public Health | 12 | 2012 | 2669 | 0.750 |
Why?
|
Health Communication | 1 | 2024 | 213 | 0.720 |
Why?
|
Internationality | 4 | 2017 | 1001 | 0.720 |
Why?
|
Disease Outbreaks | 6 | 2009 | 1749 | 0.710 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2022 | 219 | 0.710 |
Why?
|
Research Support as Topic | 2 | 2015 | 697 | 0.680 |
Why?
|
Health Personnel | 5 | 2024 | 3335 | 0.670 |
Why?
|
United States Environmental Protection Agency | 1 | 2020 | 139 | 0.670 |
Why?
|
Vaccines | 2 | 2024 | 844 | 0.670 |
Why?
|
Influenza, Human | 5 | 2014 | 1521 | 0.650 |
Why?
|
Research | 5 | 2020 | 1982 | 0.650 |
Why?
|
Communicable Disease Control | 5 | 2022 | 846 | 0.630 |
Why?
|
Medicine | 3 | 2024 | 942 | 0.620 |
Why?
|
Public Health Administration | 2 | 2022 | 242 | 0.620 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2015 | 793 | 0.620 |
Why?
|
Health Promotion | 7 | 2013 | 2214 | 0.620 |
Why?
|
Pandemics | 5 | 2024 | 8656 | 0.570 |
Why?
|
Quality of Health Care | 7 | 2021 | 4330 | 0.550 |
Why?
|
Infection Control | 2 | 2021 | 982 | 0.540 |
Why?
|
Conflict of Interest | 3 | 2017 | 554 | 0.520 |
Why?
|
Systems Analysis | 1 | 2016 | 169 | 0.520 |
Why?
|
Biomedical Research | 6 | 2022 | 3429 | 0.520 |
Why?
|
Rehabilitation | 2 | 2007 | 130 | 0.510 |
Why?
|
Public Policy | 3 | 2017 | 559 | 0.500 |
Why?
|
Capital Financing | 1 | 2015 | 58 | 0.480 |
Why?
|
United States | 67 | 2022 | 72335 | 0.470 |
Why?
|
Virus Diseases | 2 | 2015 | 718 | 0.470 |
Why?
|
Budgets | 2 | 2013 | 230 | 0.470 |
Why?
|
Federal Government | 3 | 2015 | 267 | 0.460 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3086 | 0.450 |
Why?
|
Spirurida Infections | 1 | 2013 | 3 | 0.440 |
Why?
|
Life Expectancy | 5 | 2014 | 1242 | 0.420 |
Why?
|
Social Values | 2 | 2013 | 225 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3206 | 0.410 |
Why?
|
Poliomyelitis | 1 | 2013 | 92 | 0.410 |
Why?
|
Government | 1 | 2012 | 161 | 0.390 |
Why?
|
Surgical Procedures, Operative | 3 | 2021 | 1924 | 0.380 |
Why?
|
Health Services Research | 4 | 2015 | 1812 | 0.380 |
Why?
|
Influenza Vaccines | 2 | 2009 | 768 | 0.370 |
Why?
|
Viruses | 1 | 2015 | 375 | 0.370 |
Why?
|
Drug Approval | 2 | 2008 | 814 | 0.350 |
Why?
|
Health Care Reform | 3 | 2010 | 1247 | 0.330 |
Why?
|
Acquired Immunodeficiency Syndrome | 9 | 1991 | 2199 | 0.330 |
Why?
|
Pertussis Vaccine | 4 | 1993 | 39 | 0.330 |
Why?
|
Medication Errors | 2 | 2006 | 783 | 0.320 |
Why?
|
Mortality | 1 | 2020 | 2901 | 0.320 |
Why?
|
United States Food and Drug Administration | 3 | 2007 | 1664 | 0.310 |
Why?
|
Rubella Vaccine | 3 | 1992 | 23 | 0.310 |
Why?
|
Psychiatry | 2 | 2019 | 1693 | 0.300 |
Why?
|
Humans | 125 | 2024 | 761578 | 0.290 |
Why?
|
Informed Consent | 2 | 2008 | 1008 | 0.290 |
Why?
|
Polybrominated Biphenyls | 1 | 2007 | 25 | 0.290 |
Why?
|
Mercury Poisoning | 1 | 2007 | 32 | 0.290 |
Why?
|
Efficiency, Organizational | 1 | 2012 | 695 | 0.290 |
Why?
|
Education, Medical | 7 | 2011 | 1725 | 0.280 |
Why?
|
Anti-Retroviral Agents | 1 | 2017 | 1784 | 0.280 |
Why?
|
Feeding Behavior | 4 | 2007 | 3188 | 0.280 |
Why?
|
Tuberculosis | 6 | 2001 | 2017 | 0.280 |
Why?
|
Tobacco Use Cessation | 1 | 2008 | 94 | 0.270 |
Why?
|
Obesity | 5 | 2013 | 12947 | 0.270 |
Why?
|
Consumer Product Safety | 1 | 2007 | 122 | 0.270 |
Why?
|
Forecasting | 6 | 2022 | 2928 | 0.260 |
Why?
|
Genetic Engineering | 1 | 2011 | 933 | 0.260 |
Why?
|
Biological Evolution | 1 | 2011 | 1071 | 0.260 |
Why?
|
Health Services for the Aged | 1 | 2008 | 259 | 0.260 |
Why?
|
Food Industry | 1 | 2006 | 67 | 0.260 |
Why?
|
Cost-Benefit Analysis | 14 | 2024 | 5492 | 0.250 |
Why?
|
Continuity of Patient Care | 2 | 2012 | 1069 | 0.250 |
Why?
|
Practice Guidelines as Topic | 5 | 2014 | 7391 | 0.250 |
Why?
|
Cost of Illness | 2 | 2013 | 1936 | 0.240 |
Why?
|
Drug Labeling | 1 | 2007 | 248 | 0.240 |
Why?
|
Confidentiality | 1 | 2008 | 609 | 0.230 |
Why?
|
Health Planning | 1 | 2005 | 230 | 0.230 |
Why?
|
Diet Therapy | 1 | 2005 | 151 | 0.230 |
Why?
|
Food Preferences | 1 | 2007 | 398 | 0.230 |
Why?
|
School Health Services | 1 | 2007 | 384 | 0.230 |
Why?
|
Seafood | 1 | 2007 | 393 | 0.230 |
Why?
|
Clinical Trials as Topic | 5 | 2008 | 8002 | 0.220 |
Why?
|
History, 20th Century | 4 | 2021 | 2767 | 0.220 |
Why?
|
Bioterrorism | 1 | 2004 | 144 | 0.220 |
Why?
|
Leadership | 1 | 2013 | 1385 | 0.220 |
Why?
|
Child Welfare | 1 | 2007 | 521 | 0.220 |
Why?
|
BCG Vaccine | 5 | 2001 | 369 | 0.220 |
Why?
|
Malaria | 1 | 2013 | 1227 | 0.220 |
Why?
|
International Cooperation | 5 | 2011 | 1422 | 0.210 |
Why?
|
National Health Programs | 1 | 2006 | 440 | 0.210 |
Why?
|
Nutrition Policy | 1 | 2007 | 471 | 0.210 |
Why?
|
Patient Participation | 2 | 2012 | 1445 | 0.210 |
Why?
|
History, 21st Century | 3 | 2021 | 1567 | 0.210 |
Why?
|
Health Education | 3 | 2013 | 1052 | 0.210 |
Why?
|
Health Status | 2 | 2013 | 4077 | 0.200 |
Why?
|
Human Rights | 2 | 2017 | 309 | 0.200 |
Why?
|
Needs Assessment | 1 | 2008 | 1139 | 0.200 |
Why?
|
Patient Care Team | 2 | 2012 | 2521 | 0.190 |
Why?
|
Disease Management | 1 | 2012 | 2508 | 0.190 |
Why?
|
Disclosure | 1 | 2007 | 748 | 0.190 |
Why?
|
Chronic Disease | 3 | 2013 | 9319 | 0.190 |
Why?
|
Influenza in Birds | 2 | 2015 | 76 | 0.180 |
Why?
|
Birds | 2 | 2015 | 168 | 0.180 |
Why?
|
Physicians | 4 | 2017 | 4591 | 0.180 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2005 | 452 | 0.180 |
Why?
|
Disabled Persons | 2 | 2007 | 1225 | 0.180 |
Why?
|
Geriatric Assessment | 1 | 2008 | 1410 | 0.180 |
Why?
|
Commerce | 1 | 2006 | 606 | 0.180 |
Why?
|
Technology Assessment, Biomedical | 4 | 1986 | 307 | 0.180 |
Why?
|
Wounds and Injuries | 1 | 2013 | 2491 | 0.180 |
Why?
|
Influenza A Virus, H5N1 Subtype | 2 | 2015 | 113 | 0.180 |
Why?
|
Hospital Bed Capacity | 1 | 2021 | 206 | 0.170 |
Why?
|
Protective Clothing | 1 | 2020 | 103 | 0.170 |
Why?
|
Models, Theoretical | 5 | 2001 | 3575 | 0.170 |
Why?
|
Health Expenditures | 2 | 2012 | 2366 | 0.170 |
Why?
|
Anniversaries and Special Events | 1 | 2020 | 95 | 0.170 |
Why?
|
Transplantation, Heterologous | 2 | 1998 | 2386 | 0.170 |
Why?
|
Mental Disorders | 1 | 2019 | 6845 | 0.160 |
Why?
|
Decision Making | 9 | 2016 | 3929 | 0.160 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2020 | 239 | 0.160 |
Why?
|
Risk Reduction Behavior | 1 | 2005 | 1112 | 0.160 |
Why?
|
Politics | 2 | 2017 | 815 | 0.150 |
Why?
|
Exercise Therapy | 1 | 2005 | 929 | 0.150 |
Why?
|
Diffusion of Innovation | 4 | 2014 | 728 | 0.150 |
Why?
|
Vaccination | 3 | 2022 | 3384 | 0.150 |
Why?
|
Risk Assessment | 7 | 2007 | 23996 | 0.150 |
Why?
|
Exercise | 2 | 2024 | 5890 | 0.140 |
Why?
|
Cost Savings | 2 | 2013 | 913 | 0.140 |
Why?
|
Perception | 1 | 2024 | 1197 | 0.140 |
Why?
|
Women's Health | 2 | 2005 | 2065 | 0.140 |
Why?
|
Neoplasms | 4 | 2012 | 22172 | 0.130 |
Why?
|
Interpersonal Relations | 2 | 2017 | 1436 | 0.130 |
Why?
|
Mass Screening | 5 | 2005 | 5428 | 0.130 |
Why?
|
Patient Education as Topic | 4 | 2013 | 2319 | 0.120 |
Why?
|
Survivors | 1 | 2006 | 2371 | 0.120 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 2 | 1992 | 52 | 0.120 |
Why?
|
Physician-Patient Relations | 1 | 2008 | 3249 | 0.120 |
Why?
|
Foreign Professional Personnel | 1 | 2014 | 9 | 0.120 |
Why?
|
Mexico | 2 | 2007 | 764 | 0.120 |
Why?
|
Mammography | 1 | 2005 | 2430 | 0.120 |
Why?
|
Schools, Public Health | 1 | 1994 | 23 | 0.110 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2015 | 137 | 0.110 |
Why?
|
Bed Occupancy | 1 | 2013 | 38 | 0.110 |
Why?
|
Tuberculosis, Multidrug-Resistant | 2 | 1999 | 934 | 0.110 |
Why?
|
Urbanization | 1 | 2014 | 100 | 0.110 |
Why?
|
Economics | 1 | 2014 | 141 | 0.110 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 1993 | 68 | 0.110 |
Why?
|
World Health Organization | 2 | 2014 | 1322 | 0.100 |
Why?
|
Pneumococcal Infections | 1 | 2016 | 501 | 0.100 |
Why?
|
Reimbursement Mechanisms | 2 | 2010 | 667 | 0.100 |
Why?
|
Advisory Committees | 2 | 2011 | 787 | 0.100 |
Why?
|
Sodium Hypochlorite | 1 | 1991 | 31 | 0.100 |
Why?
|
Medical Assistance | 1 | 2012 | 108 | 0.100 |
Why?
|
Schools, Medical | 1 | 1998 | 879 | 0.090 |
Why?
|
South Africa | 1 | 2017 | 1843 | 0.090 |
Why?
|
Genetics | 1 | 2011 | 114 | 0.090 |
Why?
|
Smoking | 1 | 2008 | 9053 | 0.090 |
Why?
|
Interprofessional Relations | 1 | 2017 | 990 | 0.090 |
Why?
|
Health | 1 | 1994 | 398 | 0.090 |
Why?
|
Education, Professional | 1 | 2010 | 52 | 0.090 |
Why?
|
Medical Informatics | 2 | 2021 | 733 | 0.090 |
Why?
|
Financing, Government | 1 | 2013 | 472 | 0.090 |
Why?
|
Arthritis | 2 | 1992 | 680 | 0.090 |
Why?
|
Education, Nursing | 1 | 2010 | 80 | 0.080 |
Why?
|
Disinfection | 1 | 1991 | 211 | 0.080 |
Why?
|
Program Evaluation | 1 | 1998 | 2495 | 0.080 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1996 | 832 | 0.080 |
Why?
|
Social Responsibility | 1 | 2012 | 386 | 0.080 |
Why?
|
HIV Seroprevalence | 1 | 1989 | 89 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 12 | 1983 | 20569 | 0.080 |
Why?
|
Physician Incentive Plans | 1 | 2010 | 164 | 0.080 |
Why?
|
AIDS Serodiagnosis | 1 | 1990 | 220 | 0.080 |
Why?
|
Holistic Health | 1 | 2008 | 48 | 0.080 |
Why?
|
Needles | 1 | 1991 | 451 | 0.080 |
Why?
|
Evaluation Studies as Topic | 8 | 1994 | 1624 | 0.080 |
Why?
|
Premarital Examinations | 1 | 1987 | 5 | 0.080 |
Why?
|
Opportunistic Infections | 1 | 1991 | 376 | 0.080 |
Why?
|
Health Behavior | 2 | 2013 | 2644 | 0.070 |
Why?
|
Employment, Supported | 1 | 2007 | 29 | 0.070 |
Why?
|
Probability | 7 | 1996 | 2477 | 0.070 |
Why?
|
Rehabilitation, Vocational | 1 | 2007 | 81 | 0.070 |
Why?
|
Brain Diseases | 2 | 1993 | 1546 | 0.070 |
Why?
|
Hospitals | 3 | 2013 | 3882 | 0.070 |
Why?
|
Safety | 3 | 2009 | 1149 | 0.070 |
Why?
|
Japan | 1 | 2011 | 1378 | 0.070 |
Why?
|
Clinical Competence | 2 | 2021 | 4793 | 0.070 |
Why?
|
Social Environment | 1 | 2012 | 1020 | 0.070 |
Why?
|
Substance Abuse, Intravenous | 1 | 1991 | 529 | 0.070 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2006 | 102 | 0.070 |
Why?
|
Antitubercular Agents | 3 | 2001 | 1375 | 0.070 |
Why?
|
Social Security | 1 | 2007 | 101 | 0.070 |
Why?
|
Curriculum | 2 | 2010 | 3743 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 931 | 0.070 |
Why?
|
Occupational Therapy | 1 | 2007 | 139 | 0.070 |
Why?
|
Child | 10 | 2013 | 80157 | 0.070 |
Why?
|
Risk | 8 | 2001 | 9610 | 0.070 |
Why?
|
Medication Systems, Hospital | 1 | 2006 | 154 | 0.070 |
Why?
|
Antibodies, Viral | 2 | 1987 | 3156 | 0.060 |
Why?
|
Coronary Disease | 4 | 1987 | 5914 | 0.060 |
Why?
|
Pharmacy Service, Hospital | 1 | 2006 | 134 | 0.060 |
Why?
|
Social Adjustment | 1 | 2007 | 632 | 0.060 |
Why?
|
HIV Infections | 6 | 1997 | 17352 | 0.060 |
Why?
|
Travel | 1 | 1991 | 796 | 0.060 |
Why?
|
Students, Medical | 2 | 1998 | 1936 | 0.060 |
Why?
|
Health Services | 1 | 1990 | 752 | 0.060 |
Why?
|
Costs and Cost Analysis | 6 | 1990 | 1668 | 0.060 |
Why?
|
Smallpox | 1 | 2004 | 43 | 0.060 |
Why?
|
Technology, Radiologic | 3 | 1983 | 160 | 0.060 |
Why?
|
Nutrition Assessment | 1 | 2007 | 728 | 0.060 |
Why?
|
Resource Allocation | 3 | 1994 | 350 | 0.060 |
Why?
|
Prospective Payment System | 1 | 1985 | 136 | 0.060 |
Why?
|
Coronary Care Units | 2 | 1984 | 235 | 0.050 |
Why?
|
Medicare | 3 | 2013 | 6770 | 0.050 |
Why?
|
Diagnosis-Related Groups | 1 | 1985 | 449 | 0.050 |
Why?
|
Transplantation | 1 | 1984 | 219 | 0.050 |
Why?
|
Animals | 9 | 2015 | 168475 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 1993 | 1667 | 0.050 |
Why?
|
Organizational Policy | 1 | 2005 | 432 | 0.050 |
Why?
|
Polymyalgia Rheumatica | 1 | 1983 | 52 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26127 | 0.050 |
Why?
|
Therapeutics | 2 | 1979 | 113 | 0.050 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2012 | 1188 | 0.050 |
Why?
|
Developed Countries | 2 | 2010 | 449 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2220 | 0.050 |
Why?
|
Socioeconomic Factors | 2 | 2012 | 7827 | 0.050 |
Why?
|
Cimetidine | 1 | 1981 | 76 | 0.050 |
Why?
|
Hospitalization | 2 | 2021 | 10721 | 0.050 |
Why?
|
HIV | 3 | 2020 | 1582 | 0.050 |
Why?
|
Economics, Medical | 1 | 1982 | 112 | 0.050 |
Why?
|
Social Change | 2 | 2010 | 153 | 0.050 |
Why?
|
Guanidines | 1 | 1981 | 194 | 0.040 |
Why?
|
Disaster Planning | 1 | 2006 | 557 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2007 | 1836 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8528 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3688 | 0.040 |
Why?
|
Peptic Ulcer | 1 | 1981 | 217 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 2169 | 0.040 |
Why?
|
Leukocyte Count | 1 | 1984 | 1596 | 0.040 |
Why?
|
Anesthesia, Inhalation | 1 | 1980 | 220 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 1998 | 1386 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2022 | 367 | 0.040 |
Why?
|
Developing Countries | 3 | 2010 | 2885 | 0.040 |
Why?
|
Voluntary Programs | 2 | 1990 | 48 | 0.040 |
Why?
|
Organizational Innovation | 2 | 2010 | 537 | 0.040 |
Why?
|
Drug Industry | 1 | 2005 | 788 | 0.040 |
Why?
|
Giant Cell Arteritis | 1 | 1983 | 306 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2014 | 3358 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2020 | 318 | 0.040 |
Why?
|
Animal Experimentation | 1 | 1998 | 46 | 0.040 |
Why?
|
Ethics | 1 | 1998 | 94 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2005 | 21019 | 0.040 |
Why?
|
Anesthetics | 2 | 1980 | 523 | 0.040 |
Why?
|
Legislation, Medical | 1 | 1998 | 98 | 0.040 |
Why?
|
Social Control, Formal | 1 | 1998 | 108 | 0.040 |
Why?
|
Epidemiologic Methods | 3 | 1992 | 1336 | 0.030 |
Why?
|
Adolescent | 7 | 2007 | 88323 | 0.030 |
Why?
|
Blood Banks | 1 | 1997 | 108 | 0.030 |
Why?
|
Patient-Centered Care | 2 | 2021 | 1421 | 0.030 |
Why?
|
Diagnostic Errors | 2 | 2021 | 1265 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2004 | 1505 | 0.030 |
Why?
|
Statistics as Topic | 5 | 1985 | 2358 | 0.030 |
Why?
|
Female | 17 | 2013 | 392688 | 0.030 |
Why?
|
Bacterial Infections | 2 | 1984 | 1391 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2001 | 836 | 0.030 |
Why?
|
Genomics | 1 | 2011 | 5821 | 0.030 |
Why?
|
Technology | 1 | 1978 | 292 | 0.030 |
Why?
|
Cost Control | 3 | 1985 | 628 | 0.030 |
Why?
|
Models, Biological | 2 | 2008 | 9469 | 0.030 |
Why?
|
Periodicals as Topic | 2 | 2004 | 1463 | 0.030 |
Why?
|
Male | 18 | 2013 | 360841 | 0.030 |
Why?
|
Patient Care Planning | 2 | 1979 | 909 | 0.030 |
Why?
|
Emergency Medicine | 1 | 2004 | 1198 | 0.030 |
Why?
|
Operating Rooms | 1 | 1980 | 789 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 1983 | 1881 | 0.030 |
Why?
|
New York City | 1 | 1996 | 731 | 0.030 |
Why?
|
Infant | 4 | 2000 | 36193 | 0.030 |
Why?
|
Torture | 1 | 1994 | 67 | 0.030 |
Why?
|
Time Factors | 3 | 2013 | 39970 | 0.030 |
Why?
|
Program Development | 1 | 1999 | 1297 | 0.030 |
Why?
|
Uncertainty | 1 | 1998 | 754 | 0.030 |
Why?
|
Canada | 1 | 1998 | 2122 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2000 | 26198 | 0.030 |
Why?
|
HIV Seropositivity | 2 | 1997 | 960 | 0.030 |
Why?
|
Acute Disease | 2 | 1993 | 7237 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 1982 | 2244 | 0.020 |
Why?
|
Organizational Objectives | 1 | 1994 | 426 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2004 | 3060 | 0.020 |
Why?
|
Anesthesiology | 2 | 1980 | 1120 | 0.020 |
Why?
|
Angina Pectoris | 3 | 1984 | 959 | 0.020 |
Why?
|
Neutrophils | 1 | 1984 | 3767 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2005 | 4016 | 0.020 |
Why?
|
Age Distribution | 1 | 1996 | 2879 | 0.020 |
Why?
|
Professional Competence | 1 | 1994 | 431 | 0.020 |
Why?
|
Prevalence | 3 | 2000 | 15732 | 0.020 |
Why?
|
Health Care Rationing | 1 | 1994 | 437 | 0.020 |
Why?
|
Models, Organizational | 1 | 1994 | 546 | 0.020 |
Why?
|
HIV Antibodies | 2 | 1987 | 1303 | 0.020 |
Why?
|
Shock | 1 | 1992 | 314 | 0.020 |
Why?
|
International Agencies | 1 | 2010 | 243 | 0.020 |
Why?
|
Sociology | 1 | 1988 | 21 | 0.020 |
Why?
|
Risk Factors | 4 | 2005 | 74212 | 0.020 |
Why?
|
Contraceptive Devices, Male | 1 | 1988 | 13 | 0.020 |
Why?
|
Communication | 2 | 1983 | 3873 | 0.020 |
Why?
|
Swine | 1 | 1998 | 5915 | 0.020 |
Why?
|
Communicable Diseases | 1 | 1996 | 875 | 0.020 |
Why?
|
Legislation as Topic | 1 | 1987 | 77 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 1997 | 1998 | 0.020 |
Why?
|
Homosexuality | 1 | 1988 | 267 | 0.020 |
Why?
|
Child, Preschool | 3 | 2000 | 42231 | 0.020 |
Why?
|
Computer Simulation | 1 | 2000 | 6241 | 0.020 |
Why?
|
Adult | 11 | 2000 | 221200 | 0.020 |
Why?
|
Case-Control Studies | 2 | 1995 | 22176 | 0.020 |
Why?
|
Radionuclide Imaging | 2 | 1982 | 1972 | 0.020 |
Why?
|
Substance-Related Disorders | 2 | 1996 | 4420 | 0.020 |
Why?
|
Causality | 1 | 1992 | 1242 | 0.020 |
Why?
|
Health Resources | 2 | 1984 | 935 | 0.020 |
Why?
|
Survival Rate | 1 | 2000 | 12725 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 1997 | 3810 | 0.020 |
Why?
|
Social Justice | 1 | 1990 | 478 | 0.020 |
Why?
|
Awareness | 2 | 1987 | 648 | 0.020 |
Why?
|
Government Agencies | 1 | 1985 | 160 | 0.010 |
Why?
|
Coronary Thrombosis | 1 | 1987 | 440 | 0.010 |
Why?
|
Anaphylaxis | 1 | 1992 | 757 | 0.010 |
Why?
|
Prognosis | 1 | 2005 | 29629 | 0.010 |
Why?
|
Computers | 2 | 1984 | 593 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2001 | 5440 | 0.010 |
Why?
|
Angioplasty, Balloon | 1 | 1987 | 589 | 0.010 |
Why?
|
Hospital Units | 1 | 1984 | 142 | 0.010 |
Why?
|
Respiratory Tract Infections | 1 | 1991 | 1010 | 0.010 |
Why?
|
Home Care Services | 1 | 1990 | 648 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2008 | 58983 | 0.010 |
Why?
|
Angina Pectoris, Variant | 1 | 1982 | 53 | 0.010 |
Why?
|
Odds Ratio | 1 | 1995 | 9646 | 0.010 |
Why?
|
Massachusetts | 3 | 1983 | 8830 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1991 | 1200 | 0.010 |
Why?
|
Cardiac Complexes, Premature | 1 | 1982 | 63 | 0.010 |
Why?
|
Random Allocation | 1 | 1987 | 2395 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1980 | 5368 | 0.010 |
Why?
|
Poverty | 1 | 1994 | 2697 | 0.010 |
Why?
|
Therapeutic Equivalency | 1 | 1982 | 134 | 0.010 |
Why?
|
Duodenal Ulcer | 1 | 1981 | 121 | 0.010 |
Why?
|
Tetracycline | 1 | 1982 | 216 | 0.010 |
Why?
|
Stomach Ulcer | 1 | 1981 | 122 | 0.010 |
Why?
|
Cholecystectomy | 1 | 1983 | 406 | 0.010 |
Why?
|
False Negative Reactions | 2 | 1997 | 573 | 0.010 |
Why?
|
Explosions | 1 | 1980 | 108 | 0.010 |
Why?
|
Ethics, Medical | 1 | 1985 | 783 | 0.010 |
Why?
|
Aged | 4 | 2008 | 169308 | 0.010 |
Why?
|
Bacterial Vaccines | 1 | 1982 | 401 | 0.010 |
Why?
|
Drug and Narcotic Control | 1 | 1980 | 144 | 0.010 |
Why?
|
Middle Aged | 8 | 1996 | 220917 | 0.010 |
Why?
|
Thorax | 1 | 1982 | 555 | 0.010 |
Why?
|
Electrocardiography | 2 | 1982 | 6377 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 1983 | 1156 | 0.010 |
Why?
|
Blindness | 1 | 1983 | 584 | 0.010 |
Why?
|
Abortion, Therapeutic | 1 | 1978 | 35 | 0.010 |
Why?
|
Sexual Behavior | 1 | 1988 | 2180 | 0.010 |
Why?
|
Prospective Studies | 4 | 1992 | 54423 | 0.010 |
Why?
|
Double-Blind Method | 1 | 1992 | 12341 | 0.010 |
Why?
|
Halothane | 1 | 1978 | 200 | 0.010 |
Why?
|
Pneumoencephalography | 1 | 1977 | 22 | 0.010 |
Why?
|
Nitrous Oxide | 1 | 1978 | 166 | 0.010 |
Why?
|
Insurance, Health | 1 | 1990 | 2498 | 0.010 |
Why?
|
Angiography | 1 | 1982 | 1595 | 0.010 |
Why?
|
Education, Medical, Continuing | 2 | 1983 | 823 | 0.010 |
Why?
|
Coronary Artery Bypass | 2 | 1984 | 2188 | 0.010 |
Why?
|
Reference Values | 1 | 1984 | 4920 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 1982 | 746 | 0.010 |
Why?
|
Medicaid | 1 | 1990 | 2818 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 1982 | 730 | 0.010 |
Why?
|
Coronary Vessels | 1 | 1987 | 3096 | 0.010 |
Why?
|
Population Surveillance | 1 | 1986 | 2598 | 0.010 |
Why?
|
Data Collection | 1 | 1985 | 3322 | 0.010 |
Why?
|
Blood Donors | 1 | 1997 | 345 | 0.010 |
Why?
|
Drug Storage | 1 | 1995 | 52 | 0.010 |
Why?
|
Posture | 1 | 1979 | 957 | 0.010 |
Why?
|
Coronary Angiography | 2 | 1987 | 4471 | 0.010 |
Why?
|
Longevity | 1 | 1982 | 1065 | 0.010 |
Why?
|
Exercise Test | 1 | 1982 | 2127 | 0.010 |
Why?
|
Myocardial Infarction | 3 | 1987 | 11461 | 0.010 |
Why?
|
Mycobacterium Infections | 1 | 1995 | 122 | 0.010 |
Why?
|
Tuberculin Test | 1 | 1995 | 206 | 0.010 |
Why?
|
Climate | 1 | 1995 | 147 | 0.010 |
Why?
|
Liver Diseases | 2 | 1980 | 1297 | 0.010 |
Why?
|
MEDLINE | 1 | 1994 | 119 | 0.010 |
Why?
|
Feces | 1 | 1980 | 1497 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 1980 | 802 | 0.010 |
Why?
|
Sunlight | 1 | 1995 | 337 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 1983 | 1809 | 0.010 |
Why?
|
Ambulatory Care | 1 | 1984 | 2775 | 0.010 |
Why?
|
Geography | 1 | 1995 | 656 | 0.010 |
Why?
|
Radiotherapy | 1 | 1979 | 1499 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 1979 | 2898 | 0.010 |
Why?
|
Hodgkin Disease | 1 | 1980 | 1378 | 0.010 |
Why?
|
Retrospective Studies | 4 | 1992 | 80646 | 0.010 |
Why?
|
Community Health Services | 1 | 1977 | 656 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 1979 | 1403 | 0.010 |
Why?
|
Cerebral Angiography | 1 | 1977 | 1281 | 0.010 |
Why?
|
Burns | 1 | 1983 | 1882 | 0.010 |
Why?
|
Virulence | 1 | 1995 | 1303 | 0.010 |
Why?
|
Biopsy | 1 | 1983 | 6766 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1977 | 1474 | 0.010 |
Why?
|
Education, Medical, Undergraduate | 1 | 1979 | 1070 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1982 | 3807 | 0.010 |
Why?
|
Length of Stay | 1 | 1983 | 6426 | 0.010 |
Why?
|
Heart | 1 | 1982 | 4404 | 0.010 |
Why?
|
Bacteria | 1 | 1980 | 2199 | 0.010 |
Why?
|
Treatment Outcome | 1 | 1995 | 64684 | 0.000 |
Why?
|
Pain | 1 | 1982 | 5073 | 0.000 |
Why?
|
Pregnancy | 2 | 1979 | 29876 | 0.000 |
Why?
|
Drug Evaluation | 1 | 1987 | 641 | 0.000 |
Why?
|
Ultrasonography | 1 | 1979 | 5971 | 0.000 |
Why?
|
Hemorrhage | 1 | 1978 | 3424 | 0.000 |
Why?
|
Decision Trees | 1 | 1987 | 504 | 0.000 |
Why?
|
Regression Analysis | 1 | 1995 | 6344 | 0.000 |
Why?
|
Age Factors | 1 | 1982 | 18398 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1979 | 11120 | 0.000 |
Why?
|
Insurance, Hospitalization | 1 | 1983 | 30 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1982 | 7406 | 0.000 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1982 | 114 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 1982 | 7879 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1997 | 14665 | 0.000 |
Why?
|
Methods | 1 | 1982 | 1067 | 0.000 |
Why?
|
Fees and Charges | 1 | 1983 | 192 | 0.000 |
Why?
|
Connecticut | 1 | 1982 | 364 | 0.000 |
Why?
|
Vitamin D | 1 | 1995 | 3303 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1979 | 9281 | 0.000 |
Why?
|
Dental Caries | 1 | 1985 | 427 | 0.000 |
Why?
|
New England | 1 | 1983 | 1054 | 0.000 |
Why?
|
Behavior Therapy | 1 | 1985 | 879 | 0.000 |
Why?
|
Hospitals, University | 1 | 1980 | 564 | 0.000 |
Why?
|
Mental Processes | 1 | 1979 | 244 | 0.000 |
Why?
|
Research Design | 1 | 1994 | 6180 | 0.000 |
Why?
|
Jaundice | 1 | 1978 | 94 | 0.000 |
Why?
|
Mediastinal Diseases | 1 | 1978 | 91 | 0.000 |
Why?
|
Diagnostic Tests, Routine | 1 | 1982 | 787 | 0.000 |
Why?
|
Pancreatic Diseases | 1 | 1978 | 343 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 1977 | 9031 | 0.000 |
Why?
|
Attitude to Health | 1 | 1985 | 2025 | 0.000 |
Why?
|
Triage | 1 | 1982 | 986 | 0.000 |
Why?
|
Recurrence | 1 | 1987 | 8466 | 0.000 |
Why?
|
Bone Diseases | 1 | 1978 | 418 | 0.000 |
Why?
|
Educational Measurement | 1 | 1981 | 1255 | 0.000 |
Why?
|
Stroke Volume | 1 | 1987 | 5496 | 0.000 |
Why?
|
Faculty, Medical | 1 | 1981 | 1204 | 0.000 |
Why?
|
Life Style | 1 | 1985 | 3917 | 0.000 |
Why?
|
Teaching | 1 | 1979 | 1170 | 0.000 |
Why?
|
Lymphoma | 1 | 1978 | 1901 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1978 | 2091 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1982 | 12973 | 0.000 |
Why?
|
Attitude of Health Personnel | 1 | 1980 | 3889 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1982 | 39107 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1978 | 13382 | 0.000 |
Why?
|